Phase I pharmaceutical, device, and diagnostic clinical trials
Aventiv Research currently operates in in 2 states with 4 independent sites and has access to a patient database of more than 40,000 patients. We specialize in phase I-IV pharmaceutical, device, and diagnostic clinical trials in a variety of therapeutic areas.
We utilize CRIO, the industry’s leading eSource, CTMS, and eRegulatory software for clinical trial sites. CRIO is a holistic paperless platform for conducting clinical trials that reduces data errors, streamlines regulatory workflows, and accelerates timelines.
To date, we’ve conducted over 450 clinical trials with more than 55 pharmaceutical sponsors and have helped 23 drugs to become approved by the FDA and available for use. We’re proud of our excellent reputation in the industry and provide clean-quality data, excellent SOPs, and work with a dedicated team of caring research professionals who are CPR and IATA certified. Our facilities utilize a central IRB with rapid turnaround for regulatory, budgets, and contracts.